Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal. The PROfound trial compared the genetically targeted cancer drug olaparib – already licensed for women with breast and ovarian cancer who have BRCA […]
Read More… from Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer